Related Experiment Video
Updated: May 12, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Late calcific mitral stenosis after MitraClip procedure in a dialysis-dependent patient
Nicolas H Pope1, Scott Lim, Gorav Ailawadi
1Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA.
Abstract:
The EVEREST II trial investigated the MitraClip (Abbott Vascular, Menlo Park, CA) in patients with severe mitral regurgitation (MR) undergoing surgical procedures. Although mitral stenosis was not reported in this cohort, this trial excluded patients receiving dialysis. We report a case of a 43-year-old HIV-positive, dialysis-dependent patient with nonischemic cardiomyopathy and severe MR, who was considered at high operative risk because of frailty. She was treated with a MitraClip as part of the REALISM high-risk registry. Her symptomatic MR improved but severe symptomatic mitral stenosis developed 28 months after the MitraClip procedure. At that point, she was felt to be a better operative candidate but required open mitral valve replacement. Pathologic examination demonstrated significant calcification of the leaflets around the MitraClip devices.
Insights
The MitraClip device effectively treated severe mitral regurgitation in a high-risk patient. However, it later led to severe mitral stenosis, necessitating valve replacement.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- The EVEREST II trial evaluated the MitraClip for severe mitral regurgitation (MR), excluding dialysis patients.
- Severe MR poses significant risks, especially in frail patients with comorbidities like HIV and nonischemic cardiomyopathy.
Observation:
- A case report details a 43-year-old, HIV-positive, dialysis-dependent patient with severe MR and cardiomyopathy treated with MitraClip.
- The patient, deemed high-risk for surgery, showed initial improvement in MR symptoms post-MitraClip implantation.
Findings:
- Twenty-eight months after MitraClip implantation, the patient developed severe symptomatic mitral stenosis.
- Surgical mitral valve replacement was ultimately required, with pathologic examination revealing significant calcification around the MitraClip devices.
Implications:
- MitraClip may be a viable option for select high-risk patients with severe MR.
- Long-term complications, including device-related calcification and subsequent mitral stenosis, should be monitored in patients treated with MitraClip, particularly those with complex medical histories.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Hemodialysis II: Procedure and Complications
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation III: Medical Management
